Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Industrifinans Service was a Norwegian financial services and investment firm that served as a foundational incubator for the Norwegian biotechnology sector. Operating as part of the broader Industrifinans group, the company provided seed capital, management expertise, and administrative services to early-stage life science ventures. It is most recognized for its pivotal role in founding and developing Algeta, the radiopharmaceutical company later acquired by Bayer for $2.9 billion. Additionally, Industrifinans was instrumental in the early stages of other notable Norwegian biotechs, including PhotoCure and Nordic Nanovector. The firm's activities were eventually integrated into Formue (formerly Formuesforvaltning) following a series of corporate restructurings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Industrifinans Service.